Fenaux, P. Et Al. 2020. Luspatercept in patients with lower-risk myelodysplastic syndromes. New England Journal of Medicine , vol.382, no.2 , 140-151.

Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia-Manero, G., Buckstein, R., Santini, V., ... Díez-Campelo, M.(2020). Luspatercept in patients with lower-risk myelodysplastic syndromes. New England Journal of Medicine , vol.382, no.2, 140-151.

Fenaux, Pierre Et Al. "Luspatercept in patients with lower-risk myelodysplastic syndromes," New England Journal of Medicine , vol.382, no.2, 140-151, 2020

Fenaux, Pierre Et Al. "Luspatercept in patients with lower-risk myelodysplastic syndromes." New England Journal of Medicine , vol.382, no.2, pp.140-151, 2020

Fenaux, P. Et Al. (2020) . "Luspatercept in patients with lower-risk myelodysplastic syndromes." New England Journal of Medicine , vol.382, no.2, pp.140-151.

@article{article, author={Pierre Fenaux Et Al. }, title={Luspatercept in patients with lower-risk myelodysplastic syndromes}, journal={New England Journal of Medicine}, year=2020, pages={140-151} }